GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Intraarterial Microbubble Delivery Enhances Focused Ultrasound-Induced Blood-Brain Barrier Opening in Murine Substantia Nigra

by GOAI
Share To

A recent study has demonstrated that intraarterial microbubble delivery can enhance focused ultrasound-induced blood-brain barrier (BBB) opening in the murine substantia nigra. Researchers conducted experiments to investigate the effects of this method on BBB permeability, focusing on its potential to improve targeted drug delivery to specific brain regions.

The study utilized a murine model and combined focused ultrasound with microbubble administration via intraarterial injection. The findings revealed that this approach resulted in a more effective and localized BBB opening in the substantia nigra compared to other methods. Researchers observed increased precision and reduced off-target effects, suggesting that intraarterial delivery of microbubbles may provide a more controlled mechanism for therapeutic interventions targeting the brain. Further details about the methodology and results are available in the published article.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top